Mexican health authorities said the country must identify more than 128,000 people living with HIV who are unaware of their status [1].
This initiative is critical for Mexico to meet its national targets for diagnosis, treatment, and viral suppression by 2030. Identifying these individuals is the primary hurdle in preventing new transmissions and improving long-term health outcomes for the population.
Government officials said recent advances in the delivery of care have occurred. One key improvement includes the implementation of multi-month medication supplies, which reduces the frequency of clinic visits and helps patients maintain consistent treatment schedules.
Despite these logistical improvements, the gap in diagnosis remains a significant challenge. Health officials said the focus must now shift toward strengthening diagnostic efforts to locate the 128,000 people currently missing from the healthcare system [1].
The push for increased testing comes as part of a broader strategy to ensure that all people living with HIV have access to antiretroviral therapy. By reaching the 2030 goals, the government aims to lower the overall community viral load—a state where the virus is undetectable and cannot be transmitted to others.
While Mexico focuses on its internal targets, regional trends show varying results in the fight against the epidemic. For example, the U.S. saw a 23% decrease in new HIV infections between 2012 and 2022 [2].
“Mexico must identify more than 128,000 people living with HIV who are unaware of their status.”
The shift toward multi-month prescriptions indicates a move toward patient-centered care to increase retention in treatment. However, the reliance on a specific number of undiagnosed individuals suggests that Mexico is utilizing a 'gap analysis' model to drive its public health policy. Success by 2030 depends not on the availability of medicine, but on the efficiency of the screening infrastructure to find those who are asymptomatic or avoid testing due to social stigma.
